Daniel Rauh

45PUBLICATIONS
103CO-AUTHORS
Molecular targetsGene and molecular therapyHistorical, comparative and typological linguisticsPharmacogenomicsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 06, 2026
Structure-based scaffold hopping reveals strategies to overcome oncogenic KIT and PDGFRA mutation-driven drug-resistance in GIST.

|Mar 02, 2026
Lessons from Structural Biology for Understanding Drug Resistance in Gastrointestinal Stromal Tumors (GIST).

Giorgia Mancino, Tom Schulz, Andrea Scrima

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|May 14, 2025
Advancing TET Inhibitor Development: From Structural Insights to Biological Evaluation.

Suzanne Willems, Lejla Maksumic, Janina Niggenaber

|Jan 22, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST.

Tom Schulz, Rajesh Gontla, Alina Teuber

|Jul 08, 2024
Reply to Y. Xia et al.

Sebastian Bauer, Jonathan A Fletcher, Daniel Rauh

Pageof 8

Frequent Collaborators

20 joint publications

Matthias Philipp Müller

11 joint publications

Jörn Weisner

8 joint publications

Tom Schulz

7 joint publications

Jonas Lategahn